Safety and Effectiveness Assessment of the MakAir Artificial Ventilator

  • STATUS
    Recruiting
  • participants needed
    117
  • sponsor
    Nantes University Hospital
Updated on 19 February 2024
mechanical ventilation
pao2
FIO2
respiratory distress
covid-19
acute respiratory distress
fraction of inspired oxygen (fio2)

Summary

The objective of our study is to carry out an evaluation of the safety and the effectiveness of the use of the MakAir respirator as useful supplement in situation of shortage of technical devices of assistance to the mechanical invasive ventilation, related to COVID-19 through a protocol in 3 successive sequences.

Details
Condition Pulmonary Disease, ADULT RESPIRATORY DISTRESS SYNDROME
Age 18years - 100years
Treatment MakAir
Clinical Study IdentifierNCT04475185
SponsorNantes University Hospital
Last Modified on19 February 2024

Eligibility

Yes No Not Sure

Inclusion Criteria

Sequence 1
Patient for whom a certificate has been signed by a support person / family member / close relative independent of the sponsor
Adult
Non-hypoxemic patient (PaO2 / FiO2> 300)
Patient requiring invasive mechanical ventilation> 24 hours
Stabilized patient, i.e. not needing an increase in oxygenation for at least 6 hours
Sequence 2
Patient for whom a certificate of consent has been signed by a support person / family member / close relative independent of the sponsor
Adult
Patient with mild to moderate Acute respiratory distress syndrome (300> Pa02 / FiO2> 100)
Patient requiring invasive mechanical ventilation> 3 days
Stabilized patient, i.e. having not required an increase in oxygenation for at least 6 hours
Sequence3
Patient for whom a certificate of consent has been signed by a support person / family member / close relative independent of the sponsor or waiver due to life-threatening emergency
Adult
Patient with mild to moderate Acute respiratory distress syndrome (PaO2 / FiO2> 100) or without Acute respiratory distress syndrome
Patient requiring invasive mechanical ventilation for any duration
Situation of shortage among centers investigating technical devices for invasive ventilation to treat all patients

Exclusion Criteria

Sequence 1 and sequence 2
Patient positive or showing signs of Covid-19 infection
Tracheotomized patient
History of pulmonary emphysema or severe to moderate chronic obstructive pulmonary disease
Patient in recovery and withdrawal phase of ventilatory assistance
Pneumothorax or pneumomediastinum
Hemodynamic instability
Intracranial hypertension
Pregnant woman (A urine or blood pregnancy test must be performed for women of childbearing age)
Major protected (guardianship, curatorship and under the protection of justice)
Lack of affiliation to the French social security system
Participation in another interventional clinical trial
Sequence3
Tracheotomized patient
History of pulmonary emphysema or severe to moderate moderate chronic obstructive pulmonary disease
Patient in recovery and withdrawal phase of ventilatory assistance
Pneumothorax or pneumomediastinum
Hemodynamic instability
Intracranial hypertension
Pregnant woman (A urine or blood pregnancy test must be performed for women of childbearing age)
Major protected (guardianship, curatorship and under the protection of justice)
Lack of affiliation to the French social security system
Participation in another interventional clinical trial on mechanical ventilation
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

Study AnnotationsStudy Notes

Notes added here are public and can be viewed by anyone. Notes added here are only available to you and those who you share with.

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.